Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging

Objective To evaluate and compare MRI-based ovarian morphology in groups of women with polycystic ovary syndrome (PCOS) and controls. Methods All PCOS cases ( n  = 44) had oligo-amenorrhoea and hyperandrogenism irrespective of ovarian morphology, and fulfilled NIH/Rotterdam diagnostic criteria for P...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European radiology 2010-05, Vol.20 (5), p.1207-1213
Hauptverfasser: Barber, Thomas M., Alvey, Christopher, Greenslade, Tessa, Gooding, Mark, Barber, Debbie, Smith, Rachel, Marland, Anne, Wass, John A. H., Child, Tim, McCarthy, Mark I., Franks, Stephen, Golding, Stephen J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To evaluate and compare MRI-based ovarian morphology in groups of women with polycystic ovary syndrome (PCOS) and controls. Methods All PCOS cases ( n  = 44) had oligo-amenorrhoea and hyperandrogenism irrespective of ovarian morphology, and fulfilled NIH/Rotterdam diagnostic criteria for PCOS. All control women ( n  = 40) had normal menses and normoandrogenaemia. All subjects were of white British/Irish origin and pre-menopausal. Group comparisons were based on independent-sample t tests. Polycystic ovarian morphology was defined by at least 12 follicles 2–9 mm in diameter and/or an ovarian volume greater than 10 cm 3 . Results Ovarian morphology differed significantly in PCOS cases and controls (follicle number geometric mean [SD range] 18.6 [9.9, 35.0] vs 6.6 [3.1, 14.2], unadjusted P  = 1.3 × 10 −16 ; calculated ovarian volume 8.8 cm 3 [5.0, 15.5] vs 5.1 cm 3 [2.5, 10.3], unadjusted P  = 3.0 × 10 –7 ; peripheral follicle location in 55% vs 18% of ovaries, P  = 7.9 × 10 –6 ; visible central ovarian stroma in 61% vs 24% of ovaries, P  = 2.3 × 10 –5 ). Follicle number and calculated ovarian volume were not concordant with clinical/biochemical assignment of PCOS/control status in 36 (23%) and 52 (34%) of ovaries, respectively. Conclusion Ovarian morphology overlaps in PCOS cases and controls, emphasising the importance of considering clinical/biochemical presentation together with imaging ovarian morphology in the diagnosis of PCOS.
ISSN:0938-7994
1432-1084
DOI:10.1007/s00330-009-1643-8